CM. Impact of a folic acid-enriched diet on urinary tract function in mice treated with testosterone and estradiol. Am J Physiol Renal Physiol 308: F1431-F1443, 2015. First published April 8, 2015 doi:10.1152/ajprenal.00674.2014.-Aging men are susceptible to developing lower urinary tract symptoms, but the underlying etiology is unknown and the influence of dietary and environmental factors on them is unclear. We tested whether a folic acid-enriched diet changed urinary tract physiology and biology in control male mice and male mice with urinary dysfunction induced by exogenous testosterone and estradiol (TϩE2), which mimics changing hormone levels in aging humans. TϩE2 treatment increased mouse urine output, time between voiding events, and bladder capacity and compliance. Consumption of a folic acid-enriched diet moderated these changes without decreasing prostate wet weight or threshold voiding pressure. One potential mechanism for these changes involves water balance. TϩE2 treatment increases plasma concentrations of anti-diuretic hormone, which is offset at least in part by a folic acid-enriched diet. Another potential mechanism involves neural control of micturition. The folic acid-enriched diet, fed to TϩE2-treated mice, increased voiding frequency in response to intravesicular capsaicin infusion and increased mRNA abundance of the capsaicinsensitive cation channel transient receptor potential vanilloid subfamily member 1 (Trpv1) in L6 and S1 dorsal root ganglia (DRG) neurons. TϩE2 treatment and a folic acid-enriched diet also modified DNA methylation, which is capable of altering gene expression. We found the enriched diet increased global DNA methylation in dorsal and ventral prostate and L6 and S1 DRG. Our results are consistent with folic acid acting to slow or reverse TϩE2-mediated alteration in urinary function in part by normalizing water balance and enhancing or preserving afferent neuronal function. cystometry; mouse model; voiding; folic acid; epigenetics BENIGN PROSTATIC HYPERPLASIA (BPH) is characterized by benign enlargement of the prostate. BPH is often associated with lower urinary tract symptoms (LUTS) that can include increased urinary frequency and urgency, increased nighttime urination, pain, weak stream, hesitancy, dribbling, incomplete emptying, and incontinence (25). Approximately 70% of men over age 70 experience BPH and/or LUTS (5).Aging-related changes in plasma hormone concentrations are potential driving factors in the onset and progression of BPH and LUTS. Plasma testosterone concentration declines as men age, while estradiol concentration remains the same or even rises (13). Rodents treated with testosterone and estradiol (TϩE2) to mimic this aging-associated hormonal milieu develop enlarged prostates, narrow prostatic urethras, and retain urine in a manner consistent with bladder outlet obstruction (4, 27).Our group and others have been elucidating proliferative growth pathways in developing prostates with the goal of examining whether these pathways are activated inappropri...